2932

miR-103 for cancer treatment (LYMPHOMA and LEUKEMIA)

Yefenof Eitan, HUJI, School of Medicine - IMRIC, Immunology and Cancer Research
Additional material on the technology can be supplied upon request

Contact for more information:

Shoshana Keynan
VP, Head of Business Development, Healthcare
+972-2-6586683
Contact ME:
Image CAPTCHA